Discontinuation report VAN-RIZATRIPTAN

Last updated on 2018-08-17 History
Report ID 58492
Drug Identification Number 02428512
Brand name VAN-RIZATRIPTAN
Common or Proper name RIZATRIPTAN (RIZATRIPTAN BENZOATE)
Company Name VANC PHARMACEUTICALS INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 12
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-03-31
Remaining supply date 2018-03-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2639 VIKING WAY, UNIT 210
RICHMOND, BRITISH COLUMBIA
CANADA V6V 3B7
Company contact information info@vancpharm.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-08-17 French Compare
v1 2018-08-17 English Compare

Showing 1 to 2 of 2